GCL
RPTP

Glazer Capital LLC’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Glazer Capital LLC’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-301,384
Closed -$2.7M – 118
2016
Q3 		$2.7M Buy
+301,384
New +$2.14M 0.53% 39

Glazer Capital LLC's RPTP Position: Q4 2016 in Review

Glazer Capital LLC sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 301,384 shares — an estimated $2.7M sold.

Glazer Capital LLC first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $2.7M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Glazer Capital LLC reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Glazer Capital LLC sold 301,384 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $2.7M.
  • Glazer Capital LLC first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Glazer Capital LLC's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.7M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Glazer Capital LLC's 13F filing for Q4 2016, filed 14 Feb 2017.